A practical reference on gastric protein: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-03-19. Anything still debated is marked as such rather than presented as settled.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic pentadecapeptide | Fifteen amino acids; sequence matches a fragment of a gastric juice protein |
| Molecular formula | C62H98N16O22 | Corresponds to a molecular mass near 1419 Da |
| Primary origin | Fragment of human gastric juice protein BPC | First characterized in the early 1990s |
| Common synonyms | BPC 157; PL 14736; pentadecapeptide BPC 157 | Naming conventions vary across publications |
| Reported stability | Stable in gastric juice during in vitro incubation | Based on laboratory incubation, not clinical data |
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
During the trial of alleged 9/11 conspirator Zacarias Moussaoui, the U.S. government identified five people as having been completely aware of the operation's details; bin Laden, Mohammed, Mohammed Atef, Abu Turab al-Urduni, and bin al-Shibh. The attacks were conceived by Khalid Sheikh Mohammed, who first presented it to bin Laden in 1996. Many targets were listed that al-Qaeda hijackers could crash planes into, including the Library Tower (now the U.S. Bank Tower) in Los Angeles. Bin Laden rejected the plan for being too elaborate. Al-Qaeda's first attacks against the U.S. after Bin Laden's 1998 fatwa were the 1998 African embassy bombings. In late 1998 or early 1999, bin Laden approved Mohammed to go forward with a new version of the 1996 plan. Bin Laden provided leadership and financial support, and was involved in selecting participants. Atef provided operational support, including target selections and helping arrange travel for the hijackers. He initially selected Nawaf al-Hazmi and Khalid al-Mihdhar, both experienced jihadists who had fought in the Bosnian war. The two arrived in the United States in mid-January 2000. In early 2000, they took flying lessons in San Diego, California. Both spoke little English. They performed poorly in flying lessons, and so they eventually served as secondary "muscle" hijackers. The Hamburg cell in Germany included Islamists who were key operatives in the 9/11 attacks. In late 1999, cell members bin al-Shibh, Mohamed Atta, Marwan al-Shehhi, and Ziad Jarrah arrived to meet al-Qaeda in Afghanistan.
In North America: Alphora, Delmar and NAEJA, all Canada. AMRI, Aptuit, Cambridge Major, ChemBridge, Innocentive, Irix Pharmaceuticals and PharmEco, all USA. In Europe: Carbogen-Amcis, Switzerland; Chemcomm, Germany; ChemDiv, Russia; Clauson-Kaas, Denmark; Enamine Ltd, Ukraine; Girindus, Germany; Nerviano Medical Sciences, Italy; Recipharm, Sweden; Serichim, Italy; Solvias, Switzerland, Netherlands. In Asia: BioDuro, Medicilon, Pharmaron and WuXi AppTec, all China; Acoris, Aptuit Laurus, Biocon/Syngene, Chembiotek, Chempartner and ProCitius, all India; NARD Institute and Riken, both Japan. The business of CROs is usually done through a "pay for service" arrangement. Unlike manufacturing companies, invoicing of CROs is not based on unit product price, but on full-time equivalents (FTEs), or the cost of a scientist working one year on a given customer assignment. Companies offering both contract research and manufacturing services (CRAMS) combine the activities of CROs and CMOs. Their history is either a forward integration of a CRO, which adds industrial scale capabilities, or backwards integration of a CMO. As there are only limited synergies (>90% of the projects end at the sample preparation stage), it is questionable if one-stop shops really fulfil a need. Large fine chemical companies consider the preparation of samples more as marketing tool (and expense) rather than a profit contributor.
=== Autologous fat transplant === This variation of the procedure uses the patient's own fat cells, and therefore is non-allergenic and non-immunogenic. The fat cells are taken from the abdominal wall by suction. Then they are purified and put into a saline solution before injection. When used in other fields such as urology or facial surgery, autologous fat transplants have very rarely been reported to cause fat embolism and stroke. This material is also subject to rapid digestion and migration.
== Prognosis == Studies of the life expectancy of patients with Alport syndrome are rare, but one 2012 study found that Alport patients receiving renal replacement therapy (dialysis or kidney transplantation) exhibited, on average, better survival compared with matched controls who had other kidney diseases (and who also received renal replacement therapy).
Sources: en.wikipedia.org
Interestingly, most of these mutations lead to exon skipping, and produce a shorter polypeptide, in which the Gly-Xaa-Yaa triplets stay in frame and there are no premature termination codons. Although vEDS is typically inherited in an autosomal-dominant manner, rare individuals with biallelic (homozygous or compound-heterozygous) COL3A1 variants – frequently null alleles – have an autosomal-recessive form of the disorder. The functional consequences of COL3A1 mutations can be studied in a cell culture system. A small punch biopsy of skin is obtained from the patient and used to start the culture of skin fibroblasts which express type III collagen. The type III collagen protein synthesized by these cells can be studied for its thermal stability. In other words, the collagens can be subjected to a short digestion by proteinases called trypsin and chymotrypsin at increasing temperatures. Intact type III collagen molecules, which have formed a stable triple helix, can withstand such treatment till about 41 °C, whereas molecules with mutations that lead to glycine substitutions fall apart at a much lower temperature. It is difficult to predict the clinical severity based on the type and location of COL3A1 mutations. Another important clinical implication is that several studies have reported on mosaicism. This refers to a situation where one of the parents carries the mutation in some, but not all of her or his cells, and appears phenotypically healthy, but has more than one affected offspring.
=== Initial chemical classification === In the periodic table published by Dmitri Mendeleev in 1869, thorium and the rare-earth elements were placed outside the main body of the table, at the end of each vertical period after the alkaline earth metals. This reflected the belief at that time that thorium and the rare-earth metals were divalent. With the later recognition that the rare earths were mostly trivalent and thorium was tetravalent, Mendeleev moved cerium and thorium to group IV in 1871, which also contained the modern carbon group (group 14) and titanium group (group 4), because their maximum oxidation state was +4. Cerium was soon removed from the main body of the table and placed in a separate lanthanide series; thorium was left with group 4 as it had similar properties to its supposed lighter congeners in that group, such as titanium and zirconium.
Later, though, the Community Mental Health Centers focus shifted to providing psychotherapy for those with acute but less serious mental disorders. Ultimately there were no arrangements made for actively following and treating severely mentally ill patients who were being discharged from hospitals, resulting in a large population of chronically homeless people with mental illness.
Cuba's economy is dependent on foreign oil with most oil historically imported from Venezuela and Mexico. Recent but persistent issues with Cuba's economy and electrical grid triggered the 2024–2026 Cuban protests and 2024–2026 Cuba blackouts. In December 2025, as part of the escalation that ended with the United States intervention in Venezuela, the United States seized tankers with Venezuelan oil destined for Cuba and declared a blockade on exports of Venezuelan oil. After the Venezuela intervention by the U.S. that led to the capture of incumbent Venezuelan president Nicolás Maduro, Trump threatened potential military action towards multiple territories like Greenland, Colombia, Iran, and Cuba. On 29 January 2026, Executive Order 14380 was signed and entered into force on 30 January, declaring a national emergency in U.S. and authorizing the imposition of additional tariffs on imports into the United States from countries that directly or indirectly supply oil to Cuba. The United States confirmed that regime change in Cuba is a goal by the end of the year, asking the government of First Secretary of the Communist Party of Cuba Miguel Díaz-Canel to "make a deal before it's too late".
A cystocele, also known as a prolapsed bladder, is a medical condition in which a woman's bladder bulges into her vagina. Some may have no symptoms. Others may have trouble starting urination, urinary incontinence, or frequent urination. Complications may include recurrent urinary tract infections and urinary retention. Cystocele and a prolapsed urethra often occur together and is called a cystourethrocele. Cystocele can negatively affect quality of life. Causes include childbirth, constipation, chronic cough, heavy lifting, hysterectomy, genetics, and being overweight. The underlying mechanism involves weakening of muscles and connective tissue between the bladder and vagina. Diagnosis is often based on symptoms and examination. If the cystocele causes few symptoms, avoiding heavy lifting or straining may be all that is recommended. In those with more significant symptoms a vaginal pessary, pelvic muscle exercises, or surgery may be recommended. The type of surgery typically done is known as a colporrhaphy. The condition becomes more common with age. About a third of women over the age of 50 are affected to some degree.
Sources: en.wikipedia.org
=== Repetitions and sets === In strength training, an exercise is commonly performed several times in a row. Each performance is known as a repetition. Two or more repetitions make a set. For each repetition, a person moves through one or more stages of movement. This may involve an eccentric phase where a muscle lengthens, and a concentric phase where it shortens. Each phase is preceded by a preparatory and preloading phase, and followed by a recovery phase. For example, someone doing a press up exercise will position themselves on their hands and feet with their body straight. They then begin a repetition: they prepare to lower themselves, then they bend their arms and lower themselves (called the eccentric phase due to the lengthening of the triceps), they then stop themselves close to the floor and recover their energy- the recovery may be very briefly performed or may take longer depending on how tired they are. They then prepare to raise themselves making whatever adjustments to their position as they feel are needed and preloading themselves in terms of energy, they then straighten their arms and raise themselves (the concentric phase), and at the top of the movement they stop and recover- the recovery in this position is significantly greater than in the lower position. The repetition cycle is then repeated beginning with a new preparatory phase. For different exercises the cycle may alter but will always contain preparatory and recovery phases. Sets may also be performed multiple times with rest periods between them.
Butane-1,4-diol is also used as a recreational drug known by some users as "Bute", "One Comma Four", "Liquid Fantasy", "One Four Bee" or "One Four B-D-O". Some federal courts in the United States have stated that 1,4-butanediol exerts effects similar to its metabolite, GABA analogue gamma-hydroxybutyrate (GHB), but several other federal courts have ruled that it does not. 1,4-butenediol (CAS 110-64-5) may be incorrectly sold as 1,4-butanediol but should not be confused with it.
In the US, the additive is not for direct consumer sale. Lean finely textured beef can constitute up to 15% of ground beef without additional labeling, and it can be added to other meat products such as beef-based processed meats. USDA disallows the use of spinal cord, organ meat such as cow intestines, bones, and connective tissue such as tendons in LFTB. USDA requires the trimmings used to make LFTB to meet the same microbiological standards as other beef. Because of ammonium hydroxide use in its processing, the lean finely textured beef by BPI is not permitted in Canada. Health Canada stated that: "Ammonia is not permitted in Canada to be used in ground beef or meats during their production" and may not be imported, as the Canadian Food and Drugs Act requires that imported meat products meet the same standards and requirements as domestic meat. Canada does allow Cargill's citric acid-produced Finely Textured Meat (FTM) to be "used in the preparation of ground meat" and "identified as ground meat" under certain conditions. Production of mechanically separated meat via use of bones or bone-in cuts of bovine, ovine and caprine animals are prohibited in the European Union.
=== Paleochemotaxonomy === In the field of paleochemotaxonomy the presence of biogenic substances in geological sediments is useful for comparing old and modern biological samples and species. These biological markers can be used to verify the biological origin of fossils and serve as paleo-ecological markers. For example, the presence of pristane indicates that the petroleum or sediment is of marine origin, while biogenic material of non-marine origin tends to be in the form of polycyclic compounds or phytane. The biological markers also provide valuable information about the degradation reactions of biological material in geological environments. Comparing the organic material between geologically old and recent rocks shows the conservation of different biochemical processes.
According to a senior Pakistani government official cited by CBS News, Pakistan subsequently intensified diplomatic efforts to bring the US and Iran back to the negotiating table. Reports also indicated that Pakistani authorities began referring to the negotiations as part of a broader "Islamabad process", suggesting an effort to frame the engagement as an ongoing diplomatic track rather than a single round of talks. Pakistan remained in contact with both Washington and Tehran following the talks, urging a resumption of dialogue and seeking to facilitate a second round of negotiations before the expiration of the ceasefire in April 2026. On 14 April, it was reported that US and Iranian teams could be returning to Islamabad for talks to take place later in that week. Trump said on the same day that "we're more inclined to go there [Islamabad]" and that talks in Islamabad were "more likely". However, as of 20 April, it remained unclear if the Iranian side was planning to participate in the next round of talks, and on 21 April it was reported that Iran did not send any representative to the talks. The Institute for the Study of War reported a major disagreement between Iranian parliament speaker Mohammad Bagher Ghalibaf and IRGC commander Ahmad Vahidi, with Ghalibaf favoring participating in negotiations and Vahidi opposing participation.
Sources: en.wikipedia.org
It is a synthetic peptide of fifteen amino acids whose sequence matches a fragment of a protein found in human gastric juice. It is studied mainly in laboratory and animal research rather than as an approved medicine.
The letters abbreviate body protection compound, the name given to the parent protein isolated from gastric juice. The number is an identifier attached to the specific fragment, not a dose or a description of a chemical property.
The sequence corresponds to a segment of an endogenous gastric protein, but the isolated fifteen-amino-acid peptide is a synthetic construct. Whether the free fragment circulates in humans at measurable levels is not clearly established in the published literature.
It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.